Nguyen
05-13-2021, 10:23 AM
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
https://jamanetwork.com/journals/jamaoncology/fullarticle/2775599?guestAccessKey=f8c471d0-ceca-4dab-9009-686c39d4a8f5&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology&utm_term=mostread&utm_content=olf-widget_05062021
https://jamanetwork.com/journals/jamaoncology/fullarticle/2775599?guestAccessKey=f8c471d0-ceca-4dab-9009-686c39d4a8f5&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology&utm_term=mostread&utm_content=olf-widget_05062021